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Eight new thiosemicarbazone derivatives, 6-(1-trifluoroethoxy)pyridine-3-carbaldehyde thiosemicarbazone (1), 6-(4′-fluo-
rophenyl)pyridine-3-carbaldehyde thiosemicarbazone (2), 5-chloro-pyridine-3-carbaldehyde thiosemicarbazone (3), 2-chloro-5-
bromo-pyridine-3-carbaldehyde thiosemicarbazone (4), 6-(3′,4′-dimethoxyphenyl)pyridine-3-carbaldehyde thiosemicarbazone
(5), 2-chloro-5-fluor-pyridine-3-carbaldehyde thiosemicarbazone, (6), 5-iodo-pyridine-3-carbaldehyde thiosemicarbazone (7),
and 6-(3′,5′-dichlorophenyl)pyridine-3-carbaldehyde thiosemicarbazone (8) were synthesized, from the reaction of the corre-
sponding pyridine-3-carbaldehyde with thiosemicarbazide. 5e synthesized compounds were characterized by ESI-Mass, UV-
Vis, IR, and NMR (1H, 13C, 19F) spectroscopic techniques. Molar mass values and spectroscopic data are consistent with the
proposed structural formulas.5emolecular structure of 7 has been also confirmed by single crystal X-ray diffraction. In the solid
state 7 exists in the E conformation about the N2-N3 bond; 7 also presents the E conformation in solution, as evidenced by 1H
NMR spectroscopy.5e in vitro antitumor activity of the synthesized compounds was studied on six human tumor cell lines: H460
(lung large cell carcinoma), HuTu80 (duodenum adenocarcinoma), DU145 (prostate carcinoma), MCF-7 (breast adenocarci-
noma), M-14 (amelanotic melanoma), and HT-29 (colon adenocarcinoma). Furthermore, toxicity studies in 3T3 normal cells
were carried out for the prepared compounds. 5e results were expressed as IC50 and the selectivity index (SI) was calculated.
Biological studies revealed that 1 (IC50 = 3.36 to 21.35 μM) displayed the highest antiproliferative activity, as compared to the other
tested thiosemicarbazones (IC50 = 40.00 to >582.26 μM) against different types of human tumor cell lines. 1 was found to be about
twice as cytotoxic (SI = 1.82) than 5-fluorouracile (5-FU) against the M14 cell line, indicating its efficiency in inhibiting the cell
growth even at low concentrations. A slightly less efficient activity was shown by 1 towards the HuTu80 and MCF7 tumor cell
lines, as compared to that of 5-FU. 5erefore, 1 can be considered as a promising candidate to be used as a pharmacological agent,
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1. Introduction
For several years, thiosemicarbazones with general formula
R1R2CH�N-NH-(C�S)-NH2 have been attracting the at-
tention of researchers, not only because of their multi-
functional coordination modes to transition metal ions
[1, 2], but also because of their wide range of biological
properties including antibacterial [3–6], antifungal [7],
antimicobacterium tuberculosis [8, 9], and antitumoral
[10–14] activity.
5iosemicarbazones usually react as chelating ligands
with metal ions by bonding through the thiocarbonyl sulfur
and the azomethine nitrogen atoms [15–17]. In addition to
this, thiosemicarbazones and the corresponding coordina-
tion compounds have been extensively investigated for their
antriproliferative activity against different human tumor cell
lines. It has been shown that the mechanism of antitumoral
action of α-(N)-heterocyclic thiosemicarbazones is due to its
ability to inhibit the enzyme ribonucleotide diphosphate
reductase, which catalyzes the conversion of ribonucleotides
into deoxyribonucleotides during the DNA syntheses
[18, 19].
A variety of heterocyclic thiosemicarbazones also
proved to be cytotoxic against several tumor cell lines.
5us, cytotoxic studies with pyridine thiosemicarbazone
derivatives: pyridine-2-carbaldehyde thiosemicarbazone,
2-acetylpyridine- 4-cyclohexyl thiosemicarbazone, and 2-
formylpyridin-4-N-ethyl-thiosemicarbazone, revealed
that these compounds possess higher antiproliferative
activity in vitro (IC50 �< 0.55 to 4.88 μM) against MCF-7
(human breast cancer cell line), as compared to cisplatin
(IC50 = 8.0 μM) [20–22].
In previous articles, we have reported the cytotoxic activity
of compounds derived from benzaldehyde, naphthaldehyde,
and furan-2-carbaldehyde thiosemicarbazones against different
human tumor cell lines [23–25]. In vitro antitumor studies,
against the chronic myelogenous leukemia (K562) and ame-
lanoticmelanoma (M-14) cell lines, revealed that compounds 2-
hydroxynaphthaldehyde thiosemicarbazone (IC50� 0.30 and
7.30μΜ, respectively) and 4-phenyl-1-(2′-hydroxynaph-
thaldehyde) thiosemicarbazone (IC50� 0.60 and 6.40μΜ, re-
spectively) were more cytotoxic than the corresponding
naphthaldehyde thiosemicarbazone compounds (IC50�15.00
and 6.4μM, respectively) and 4-phenyl-1-naphthaldehyde
thiosemicarbazone (IC50� 24.70 and >250μΜ, respectively)
[26]. In addition, in this research compound 2-hydroxynaph-
thaldehyde thiosemicarbazonewas found to be about four times
more cytotoxic than the reference drug cisplatin against the
K562 cell line.
As a part of our efforts towards the synthesis and
structural characterization of new materials containing
biorelevant pyridinyl thiosemicarbazones and the under-
standing of their cytotoxic activity against different human
tumor cell lines, the present work describes the synthesis and
spectral characterization of eight new pyridine-3-carbalde-
hyde thiosemicarbazone derivatives. Compounds 1–8 were
tested for their in vitro antiproliferative activity against six
human tumor cell lines: H460 (lung large cell carcinoma),
HuTu80 (duodenum adenocarcinoma), DU145 (prostate
carcinoma), MCF-7 (breast adenocarcinoma), M-14 (ame-
lanotic melanoma), and HT-29 (colon adenocarcinoma).
2. Materials and Methods
2.1.Chemicals and Instrumentation. All reagents and solvents
were purchased from Sigma-Aldrich of analytical grade and
were used without further purification. 5e tested human
tumor cell lines wereH460 (lung large cell carcinoma), HuTu80
(duodenum adenocarcinoma), DU145 (prostate carcinoma),
MCF-7 (breast adenocarcinoma), M-14 (amelanotic mela-
noma), and HT-29 (colon adenocarcinoma), while the tested
non-tumor cell line consisted of BALB/3T3 mouse embryonic
fibroblast cells. Both the human tumor cell lines and the non-
tumor cells were obtained from the American Type Culture
Collection or from the National Cancer Institute. Cytotoxicity
screening was performed using the sulforhodamine B (SRB)
colorimetric assay [27].
Melting points were determined on a Büchi melting
point B-545 apparatus. Elemental analyses were determined
on an Elementar Vario EL analyzer. ESI-MS spectra were
recorded on a Waters-Quattro Premier XE™ tandem
quadrupole mass spectrometer and MicrOTOF Bruker
Daltonics mass spectrometer, using methanol as the sample
dissolution medium. 5e Infrared (IR) spectra were recor-
ded using a Nicolet iS10 Fourier Transform Infrared (FT-IR)
spectrometer equipped with an attenuated total reflectance
accessory using a diamond crystal. 5e measurements were
obtained in absorbance mode, recorded for 32 scans at a
resolution of 4 cm−1. All the measurements were carried out
with an automatic baseline correction. 5e UV-VIS spectra
were recorded on a 5ermo Scientific Evolution 201 spec-
trophotometer. 5e 1H (300MHz or 400MHz), 13C
(75.5MHz or 100MHz), and 19F (376MHz) NMR spectra
were obtained on a Varian Mercury Plus 300 or Varian
Mercury Plus 400 spectrometer at 299K, using DMSO-d6 as
solvent. 5e chemical shifts (δ) in ppm were referenced
relative to residual DMSO (2.50 ppm, 1H; 39.52 ppm, 13C
{1H}; 19F via IUPAC Ξ-scale with respect to the 1H refer-
ence). 5e splitting of proton and carbon resonances in the
reported 1H and 13C NMR spectra is defined as s= singlet,
d=doublet, t= triplet, q= quartet, and m=multiplet.
2.2. Experimental Procedures
2.2.1. Synthesis of the Pyridine-3-carbaldehyde ?io-
semicarbazone Derivatives 1–8.
General Method. 5e pyridine-2-carbaldehyde derivative
(2mmol) in 70mL of methanol was added dropwise
to a solution of the thiosemicarbazide (0.27 g, 3mmol)
in 50mL of methanol during 30 minutes. 5e mixture
was refluxed for 3 h under constant stirring.5en, this
liquid was stirred for 24 h at room temperature. 5e
final mixture was filtered and the filtrate was con-
centrated to half the volume under reduced pressure.
After a slow evaporation of the concentrate at room
temperature, a solid product was obtained. It was
filtered, washed several times with cold ethanol and
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dried in vacuo. Recrystallization of the solids was
performed from hot acetone.
6-(1-Trifluoroethoxy)pyridine-3-carbaldehyde ?io-
semicarbazone (1). Colorless solid. Yield 68%, m.p.
210–212°C. Anal. Cal. for C9H9ON4SF3 (278.25 g/mol):
C, 38.85; H, 3.26; N, 20.14. Found: C, 38.92; H, 2.51; N,
20.75. ESI-MS:m/z 279.05 [M+H]+, 301.04 [M+Na]+.
UV-VIS [DMSO, λmáx.(nm)] 317. IR (KBr): ]= 3451,
3294 (NH2), 3154 (NHCS), 1610 (CH=N), 1536 (C=N),
1059 (N-N), 865 (C=S) cm−1. 1H-NMR (300MHz, d6-
DMSO, ppm): δ 5.02 (q, 2H, OCH2CF3, J= 9.1Hz), 8.20
and 8.08 (s, 2H, NH2), 8.46 (d, 1H: H2, Py, J= 2.3Hz),
8.41 (dd, 1H: H4, Py, J = 8.6, 2.3Hz), 7.03 (d, 1H: H5, Py,
J= 8.6Hz), 8.03 (s, 1H, CH=N), 11.49 (s, =N-NH). 13C-
NMR (75MHz, d6-DMSO): δ 61.59 (q, OCH2CF3,
J= 34.6Hz), 124.04 (q, CF3, J= 277.6Hz); 161.87,
146.81, 137.64, 125.88, 111.14 (Py); 138.80 (HC=N);
178.04 (C=S). 19F{1H}-NMR (376MHz, d6-DMSO):
−72.85 (CF3).
6-(4-Fluorophenyl)pyridine-3-carbaldehyde ?iosemi-
carbazone (2 ). Colorless solid. Yield 65%, m.p.
241–243°C. Anal. Cal. for C13H11N4SF (274.32 g/mol):
C, 56.92; H, 4.04; N, 20.42. Found: C, 56.94; H, 3.14; N,
20.79. ESI-MS: m/z 275.08 [M+H]+. UV-VIS [DMSO,
λmáx.(nm)] 248, 323. IR (KBr): ]= 3422, 3273 (NH2),
3078 (NHCS), 1633 (CH=N), 1525 (C=N), 1093 (N-N),
833 (C=S) cm−1. 1H-NMR (400MHz, −d6-DMSO,
ppm): δ 7.86 (t, 2H: H2′, H6′, 4-F-Ph, J= 8.9, 5.4Hz),
7.34 (t, 2H: H3′, H5′, 4-F-Ph, J = 8.9Hz), 8.33 and 8.28
(s, 2H, NH2), 8.57 (t, 1H: H4, Py, J= 2.1Hz), 8.85 (dd,
1H: H5, Py, J= 4.9, 2.1Hz), 8.14 (s, 1H, CH=N), 11.64 (s,
1H, =N-NH). 13C-NMR (100MHz, d6-DMSO, ppm): δ
162.41 (d, F-C4′, J= 245.5Hz), 133.02 (d, J= 3.3Hz),
129.27 (d, J= 8.4Hz), 115.91 (d, J= 21.5Hz) (4-F-Ph);
148.28, 147.86, 134.43, 131.05, 130.31 (Py); 138.98
(HC=N); 178.28 (C=S). 19F{1H}-NMR (376MHz, d6-
DMSO): ‒114.54 (F-Ph).
5-Chloro-pyridine-3-carbaldehyde ?iosemicarbazone (3).
Colorless solid. Yield 56%. m.p. 240–241°C. Anal. Cal.
for C7H7N4SCl (214.68 g/mol): C, 39.16; H, 3.29; N,
26.10. Found: C, 39.09; H, 2.50; N, 26.66. ESI-MS: m/z
215.02 [M+H]+, 236.99 [M+Na]+. UV-VIS [DMSO,
λmáx.(nm)] 324. IR (KBr): ]= 3324 (NH2), 3120 (NHCS),
1629 (CH=N), 1525 (C=N), 1096 (N-N), 843 (C=S)
cm−1. 1H-NMR (300MHz, d6-DMSO, ppm): δ 8.04 (s,
1H: H4, Py), 8.79 (s, 1H: H6, Py), 8.33 (s, 2H, NH2), 8.57
(s, 1H, CH=N), 11.66 (s, 1H, =N-NH). 13C-NMR
(75MHz, d6-DMSO, ppm): δ 149.00, 147.77, 133.09,
132.42, 132.04, (Py); 137.79 (HC=N); 178.85 (C=S). (5)
2-Chloro-5-bromo-pyridine-3-carbaldehyde ?iosemi-
carbazone (4). Yellow solid. Yield 70%. m.p. 135–137°C.
Anal. Cal. for C7H6N4SBrCl (293.57 g/mol): C, 28.64; H,
2.06; N, 19.08. Found: C, 28.75; H, 1.82; N, 19.31. ESI-
MS: m/z 292.93, 294.93 [M+H]+. UV-VIS [DMSO,
λmáx.(nm)] 335. IR (KBr): ]=3446, 3238 (NH2), 3146
(NHCS), 1602 (CH=N), 1536 (C=N), 1061 (N-N), 837
(C=S) cm−1. 1H-NMR (300MHz, d6-DMSO, ppm): δ
9.02 (d, 1H4, Py, J=3.0Hz), 8.53 (d, 1H6, Py, J= 3.0Hz),
8.45 (s, 2H, NH2), 8.28 (s, 1H, CH=N), 11.77 (s, 1H, =N-
NH). 13C-NMR (75MHz, d6-DMSO, ppm): δ 150.87,
148.22, 135.73, 130.78, 120.24 (Py); 138.24 (HC=N);
178.96, 171.65 (C=S).
6-(3,4-Dimethoxyphenyl)pyridine-3-carbaldehyde ?i-
osemicarbazone (5). Yellow solid. Yield 70%, m.p.
219–221°C. Anal. Cal. for C15H16O2N4S (316.38 g/mol):
C, 56.94; H, 5.10; N, 17.71. Found: C, 56.81; H, 4.80; N,
17.54. ESI-MS: m/z 317.11 [M+H]+. UV-VIS [DMSO,
λmáx.(nm)] 351. IR (KBr): ]= 3375, 3269 (NH2), 3116
(NHCS), 1587 (CH=N), 1531 (C=N), 1018 (N-N), 832
(C=S) cm−1. 1H-NMR (300MHz, d6-DMSO, ppm): δ
3.81, 3.86 (s, 3H, CH3O-Ph), 7.98 (d, 1H: H2´, Ph,
J= 9.0Hz), 7.06 (d, 1H: H5´, Ph, J= 9.0Hz), 7.74 (s, 1H:
H6′, Ph); 8.15 and 8.28 (s, 2H, NH2); 8.90 (s, 1H: H2,
Py), 7.72 (d, 1H: H4, Py, J= 9.0Hz), 8.34 (d, 1H: H5, Py,
J= 12.0Hz); 8.09 (s, 1H, CH=N), 11.58 (s, 1H, =N-NH).
13C-NMR (75MHz, d6-DMSO, ppm): δ 149.25, 139.71,
131.17, 119.81, 112.16, 110.29 (Ph); 156.81, 150.55,
134.93, 128.61, 119.97 (Py); 149.40 (HC=N); 178.54
(C=S).
2-Chloro-5-fluor-pyridine-3-carbaldehyde ?iosemi-
carbazone (6). Colorless solid. Yield 82%. m.p.
139–140°C. Anal. Cal. for C7H6N4SFCl (232.67 g/mol):
C, 36.13; H, 2.60; N, 24.08. Found: C, 36.15; H, 2.23; N,
24.44. ESI-MS: m/z 230.91 [M−H]−. UV-VIS [DMSO,
λmáx.(nm)] 250, 334. IR (KBr): ]= 3457, 3290 (NH2),
3158 (NHCS), 1605 (CH=N), 1525 (C=N), 1067 (N-N),
840 (C=S) cm−1. 1H-NMR (400MHz, d6-DMSO, ppm):
δ 8.75 (dd, 1H: H4, Py, J= 9.5, 3.0Hz), 8.45 (d, 1H: H6,
Py, J = 3.0Hz); 8.43 and 8.40 (s, 2H, NH2); 8.30 (s, 1H,
CH=N), 11.79 (s, 1H, =N-NH). 13C-NMR (100MHz,
d6-DMSO, ppm): δ 158.82 (d, J= 253.4Hz), 143.84 (d,
J= 1.8Hz), 138.27 (d, J= 26.8Hz), 130.37 (d,
J= 5.3Hz), 122.57 (d, J= 22.2Hz) (Py); 135.48 (d,
HC=N, J= 2.0Hz); 178.98 (C=S). 19F{1H}-NMR
(376MHz, d6-DMSO): −129.36 (F-Py).
5-Iodo-pyridine-3-carbaldehyde ?iosemicarbazone (7).
Colorless solid. Yield 69%. m.p. 242–244°C. MW:
C7H7N4SI (306.13 g/mol), ESI-MS: m/z 305.00 [M−H]−.
UV-VIS [DMSO, λmáx.(nm)] 267, 325. IR (KBr): ]=3370,
3225 (NH2), 3147 (NHCS), 1683 (CH=N), 1593 (C=N),
1015 (N-N), 867 (C=S) cm−1. 1H-NMR (400MHz,
d6-DMSO, ppm): δ 8.79, (d, 1H, Py, J = 1.7Hz), 8.75–8.76
(m, 2H, Py); 8.27 (s, 2H, NH2); 7.97 (s, 1H, CH=N); 11.62
(s, 1 H, =N-NH). 13C-NMR (100MHz, d6-DMSO, ppm):
δ 155.75, 147.76, 141.25, 132.44, 94.95 (Py); 138.0
(HC=N); 178. 48 (C=S).
6-(3,5-Dichlorophenyl)pyridine-3-carbaldehyde ?iose-
micarbazone (8). Colorless solid. Yield 90%. m.p.
223–225°C. MW: C13H10N4SCl2 (325.22 g/mol), ESI-
MS:m/z 324.91 [M−H]−. UV-VIS [DMSO, λmáx.(nm)]
340. IR (KBr): ]= 3356, 3256 (NH2), 3160 (NHCS),
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1600 (CH=N), 1532 (C=N), 1105 (N-N), 804 (C=S)
cm−1. 1H-NMR (400MHz, d6-DMSO, ppm): δ 8.43 (d,
2H: H2′, H5′, Ph, J= 6.0Hz), 7.68 (s, 1H: H4′, Ph); 8.98
(s, 1H: H2, Py), 8.11 (s, 1H: H4, Py, J= 6.0Hz), 8.14 (d,
1H: H5, Py, J= 6.0Hz); 8.31 and 8.22 (s, 2H, NH2); 8.17
(s, 1H, CH=N), 11.64 (s, 1H, =N-NH). 13C-NMR
(100MHz, d6-DMSO, ppm): δ 139.07, 135.22, 125.58
(Ph); 153.65, 149.46, 130.65, 129.04, 121.28 (Py); 141.91
(HC=N); 178.70 (C=S).
2.2.2. Crystal Structure Determination. Data were collected
at 180K using a STOE StadiVari diffractometer equipped
with a copper X-ray microsource (Cu Kα radiation) and a
Dectris Pilatus 300K detector. All data were corrected for
Lorentz and polarization effects; absorption effects were
corrected based on numerical absorption corrections. In
addition, a scaling correction was performed using Stoe
X-Area software [28]. 5e structure of 7 was solved by direct
methods (ShelxS) and refined using the full-matrix least-
squares method against F2 (ShelxL) [29]. Diagrams of the
molecular structure showing thermal ellipsoids with 50%
probability were generated using Diamond3 software [30].
2.2.3. Biological Activity.
Cell Culture. BALB/3T3 cells were maintained in Dul-
becco´s modified Eagle´s medium (DMEM) supple-
mented with 10% calf serum and 50 μg/mL
gentamycin. H460, HuTu80, and DU145 were
maintained in minimal essential medium (MEM)
supplemented with 10% fetal bovine serum and 50 μg/
mL gentamycin. MCF-7 and HT-29 were maintained
in RPMI 1640 supplemented with 7.5% fetal bovine
serum and 50 μg/mL gentamycin. Cells were grown at
37°C in a 5% CO2 humidified environment.
Assessment of Cytotoxicity. In vitro cytotoxic activity of
the prepared compounds was tested using the sulfo-
rhodamine B (SRB) assay [27]. Briefly, cells were seeded
onto 96-well plates at a density of 3000–5000 cells per
well and incubated at 37°C, 5% CO2, 95%, air and 95%
relative humidity, with their corresponding growth
medium for 24 h to allow for cell attachment. Solutions
of the pyridine-3-carbaldehyde thiosemicarbazone
derivatives in DMSO at different concentrations (1.95,
7.81, 31.25, and 125 μg/mL) and solutions of 5-fluo-
rouracyl in DMSO at different concentrations (0.061,
0.244, 0.977, and 3.91 μg/mL) were added to the dif-
ferent cell lines and incubated for 48 h at 37°C in 5%
CO2 humidified atmosphere. After 48 h, cells were
treated with trichloroacetic acid (TCA), washed, dried,
and stained with a solution of 0.4% sulforhodamine B
in 1% acetic acid for 20 minutes. Excess stain was
washed out four times with 1% acetic acid. After
complete drying, the bound dye was solubilized with
10mM Tris buffer (pH 10.5) and color intensity was
measured on an automated plate reader at a wavelength
of 510 nm. 5e IC50 value was defined as the concen-
tration of test sample resulting in a 50% reduction of
absorbance as compared with untreated controls, i.e.,
50% reduction in the growth of the cells, and was
determined by linear regression analysis.
3. Results and Discussion
3.1. Synthesis and Characterization. Pyridine-3-carbaldehyde
thiosemicarbazone derivatives 1–8 were prepared by con-
densing the thiosemicarbazide with a wide range of
substituted pyridine 3-carbaldehydes, according to a liter-
ature procedure [24, 25], as shown in Scheme 1.
All the new synthesized compounds were obtained in good
yields (56–90%) and were satisfactorily characterized by ele-
mental analysis, ESI-Mass, UV-Vis (ultraviolet-visible), FT-IR,
and (1H, 13C, 19F) nuclear magnetic resonance spectroscopy.
5e isolated compounds are soluble in common organic sol-
vents, such as dichloromethane, chloroform, acetone, dime-
thylformamide, and dimethylsulphoxide.
5e mass and spectroscopic data obtained for all the
thiosemicarbazone derivatives are in agreement with the
proposed structures and are given as Supplementary
Material.
3.1.1. Infrared Spectra. 5e corresponding FT-IR spectra of
the studied compounds are given as Supplementary Material
(Figures S1–S8). In the FT-IR spectra of all eight com-
pounds, the broad bands observed in the ranges of
3457–3225 and 3158–3078 cm−1 were assigned to the ](NH2)
and ](NHCS) vibrations, respectively [31, 32]. 5e strong
and medium absorption bands at 1587–1683 cm−1 were
attributed to the (CH=N) stretching vibrations of the imine
group, which is in agreement with the vibrations found for
other thiosemicarbazone derivatives [31]. 5e strong bands
of the pyridine C=N group were observed at
1593–1525 cm−1, while the bands in the 1096–1015 cm−1
region were assigned to the ](N-N) vibrations. In all FT-IR
spectra, a peak around 2500 cm−1 attributed to the SH group
was not observed; the medium bands which are in
867–804 cm−1 range were ascribed to (C=S) stretching vi-
brations, indicating that the studied compounds are present
in the thione form [33, 34].
3.1.2. Mass Spectra. 5e mass spectra of all thio-
semicarbazones show the molecular ion peaks ([M+H]+ or
[M−H]+) corresponding to the respective molecular masses
[M] of the prepared compounds. For 4, two peaks were
observed atm/z= 292.93 and 294.94, respectively, due to the
presence of 79Br and 81Br isotopes.
3.1.3. NMR Spectra. 5e NMR spectra of the compounds
were recorded in DMSO-d6 solution in order to confirm the
presence of the functional groups and proposed molecular
formulas. 5e 1H resonances were assigned on the basis of
chemical shifts, multiplicities, and coupling constants and,
in some cases, by 2D NMR data. 5e 1H-NMR, 13C NMR,
and 19F NMR spectra of 1 are shown in Figures 1–3.
All 1H-NMR spectra of compounds 1–8 showed a
singlet in the region δ � 11.79 −11.49 for the �N-NH
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proton [35]. 5ese results are similar to the chemical
shifts found for compound 4-phenyl-1-benzaldehyde
thiosemicarbazone (δ �11.83), which exists in the E
isomeric form [23]. 5e signal of the imine–CH�N
proton appeared as a singlet at δ � 8.57 − 7.97 [36]. 5e
NH2 protons of the thioamide group showed broad peaks
at δ � 8.45 − 8.08 [23]. On the other hand, the resonance
lines of the protons corresponding to the pyridine ring
were observed at δ � 9.02 − 7.05, in agreement with the
chemical shifts found for other compounds derived from
pyridine-2-carbaldehyde thiosemicarbazone [33, 37]. For
compounds 2, 5, and 8, the aromatic proton signals of the
phenyl fragment bound to the pyridine ring were affected
by the presence of the fluoro, methoxy, and chloro sub-
stituents in the C-4′, C-3′,4′, and C-3′,5′positions, re-
































Scheme 1: Synthesis of pyridine-3-carbaldehyde thiosemicarbazone derivatives.







































































Figure 1: 1H-NMR spectrum of compound 1.
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positions C-2´ (0.27, 0.39, and 0.84 ppm, for 2, 5, and 8,
respectively), C-4´ (0.50 ppm for 8), and C-6′(0.27, 0.15,
and 0.84 ppm, for 2, 5, and 8, respectively), while for 5 the
signal of the proton in the position C-5′ is shielded by
0.29 ppm, with respect to the unsubstituted phenyl
moiety [23, 25].
In the 13C-NMR spectra of compounds 1-8, the signals of
the imine (C=N) carbon atoms appeared at
δ = 149.40−135.48. 5ese results are similar to the chemical
shifts found for the compounds (E)-N´-(pyridine-2-
ylmethylene) azepane-1-carbothiohydrazide and 2-ace-
tylpyridine-N(4)-1-(4-fluorophenyl)piperazinyl thio-
semicarbazone (δ = 146.7 and 148.48, respectively) [33, 37].
5e signals observed at δ = 178.98−171.65 correspond to the
thioamide carbons (C=S) [33, 38, 39]. 5e resonance lines of
the pyridine carbons appeared at δ = 161.87− 94.95, and
these chemical shifts are in agreement with those found for
2-benzoylpyridine-N(4)-orthofluorphenyl thio-
semicarbazone (δ = 124.96−151.18) [7]. 5e aromatic car-
bons of the phenyl group in all synthesized
thiosemicarbazones were observed at δ = 162.41−110.29
[37].
All fluorine containing compounds 1, 2, and 6 showed
19F NMR signals as expected to their respective chemical
environment (CF3-R, F-Ph, F-Py) [40].
3.2. Description of the Crystal Structure of Compound 7.
Good quality crystals of 7, suitable for single crystal X-ray
diffraction analysis, were obtained by slow evaporation from
a concentrated reaction mixture in methanol. For the other
compounds, only microcrystalline solids were obtained from
acetone. 7 crystallizes with two different crystal shapes and
different unit cells. Its molecular structure together with the
atomic numbering scheme is shown in Figure 4. Crystal data
and refinement results for both types of crystals are sum-
marized in Table 1, and selected bond lengths, bond angles,
and torsion angles are given in Table 2. 5e values in the
right column of Table 1 belong to the plate-like crystals,
which correspond to the major fraction (>90%) of crystals,
while the values in the left column belong to the minor
fraction of rod-like crystals. 5e bond lengths, bond angles,
and torsion angles for 7, shown in Table 2, are similar for
both crystal shapes. As reported in Table 1, both crystal
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Figure 2: 13C{1H}NMR spectrum of compound 1.





Figure 3: 19F{1H} NMR spectrum of compound 1.
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group P21/c with one molecule in the asymmetric unit. Both
types of crystals show the existence of the E conformation of
the compound in the solid state.
5e ORTEP diagram (Figure 4) reveals that 7 exists in
the E conformation regarding the N2-N3 bond, as evi-
denced by the C7-N2-N3-C8 torsion angle of 177.0(4).
5is E conformation was also observed in other thio-
semicarbazone derivatives [22, 25, 41, 42]. 5e bond
distances observed for the C=N (C7-N2 1.280(5) Å) and
C=S (C8-S1 1.697(3) Å) groups are very close to the bond
lengths found for the C=N (1.2831(18) and 1.2764(18) Å)
and C=S (1.6786(14) and 1.6884(14) Å) groups, corre-
sponding to compounds 2-formylpyridine-4-N-ethyl-
thiosemicarbazone and (E)-2-(2-chlorobenzylidene)-N-
methyl hydrazinecarbothioamide, respectively [22, 42].
5ese results confirm the existence of the thio-
semicarbazone group in the thione form in the solid













Figure 4: ORTEP diagram of 7 with thermal ellipsoids at the 50% probability level.
Table 1: Crystal and structure refinement data of 7 obtained as rod-like (left column) and plate-like crystals (right column).
Compound 7






a (Å) 8.8999(3) 9.6084(2)
b (Å) 4.5723(1) 7.9140(1)
c (Å) 24.7204(7) 14.0539(3)
α (°) 90 90
β (°) 94.444(2) 107.132(2)
c (°) 90 90
Volume (Å3) 1002.92(5) 1021.25(3)
Z 4 4
Density (calculated) (g/cm3) 2.027 1.991
Absorption coefficient (mm−1) 26.720 26.241
F (000) 584 584
Crystal size (mm3) 0.05× 0.06× 0.15 0.070× 0.075× 0.080








Reflections collected 10874 18535
Independent reflections 1906 [R (int)� 0.029] 1961 [R(int)� 0.029]
Completeness to θ� 70.6° 98.8% 99.6%
Data/restraints/parameters 1906/0/140 1961/0/147
Goodness-of-fit on F2 1.178 1.078
Final R indices (I> 2σ(I)) R1� 0.0252, wR2� 0.0635 R1� 0.0274, wR2� 0.0771
R Indices (all data) R1� 0.0265, wR2� 0.0639 R1� 0.0293, wR2� 0.0780
Extinction coefficient 0.00051(7) 0.0003(1)
Largest diff. Peak and hole, e.Å−3 0.69 and −0.50 0.97 and −0.74
Journal of Chemistry 7
C8-S1 bond distances are intermediate between the ideal
values of corresponding double and single bonds. 5is
indicates an extensive delocalized electron density on the
N2-N3-C8-N4 chain [41, 42].
Accordingly, the C8-N3-N2 bond angles found for both
crystal shapes (rod-like crystals: 119.2(3)° and plate-like crys-
tals: 120.4(3)°) of 7 are typical for sp2 atoms.5ey are similar to
those bond angles found for the N4-ortho, -meta and -para-
fluorophenyl 2-acetylpyridine thiosemicarbazones (118.84,
118.67 and 119.18°, respectively). Weak intramolecular hy-
drogen bonds N2. . .H4-N4 contribute to the stability of the E
conformation [43].
5e tridentate (N, N, S) compound 7 deviates only
slightly from planarity.5e displacement from coplanarity is
indicated by the dihedral angle between the pyridine ring
and the plane defined by the C3-C7-N2-N3 chain; the values
being 1.8° for the rod-like crystals and 1.1° for the plate-like
crystals. 5e packing of 7 in the rod-like crystals (Upper part
of Figure 5) supports the fact that the molecules of 7 are
involved in hydrogen bonds through the sulfur (thio-
carbonyl) and the NH group of neighbouring moieties,
S1. . .H3′-N3′ (S1. . .H3′ 2.44; S1. . .N3′ 3.35 Å;
S1. . .H3′–N3′ 167°; “: 1− x, 2− y, 1− z). 5e shortest I. . .H
distance is observed between the iodine (pyridinyl) atom I1
and the amine hydrogen atom H4b of a neighbouring
molecule (I1. . .H4b” 3.21 Å; “: 1− x, y− 0.5, 0.5− z). In
contrast, in the plate-like crystals of 7 (Lower part of Fig-
ure 5), the shortest intermolecular S· · ·H distance is sig-
nificantly longer (S1. . .H3′ 2.80 Å; “: −x, 2− y, 1− z) and the
shortest intermolecular I. . .H distance is slightly shorter
(I1. . .H2” 3.13 Å; “: x, 1.5− y, z− 0.5) than in the other
crystalline form.
Table 2: Selected bond distances (Å), bond angles (°), and torsion angles (°) of two different crystals, obtained for 7.











































Figure 5: Packing diagrams of 7 in the rod-like (a) and plate-like (b) crystals.
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3.3.AntitumorEvaluation. 5e synthesized compounds 1–8
were tested for their in vitro cytotoxic activity against the
following six human tumor cell lines: large cell lung car-
cinoma (H460), duodenum adenocarcinoma (HuTu80),
prostate carcinoma (DU145), breast adenocarcinoma
(MCF-7), amelanotic melanoma (M-14), and colon ade-
nocarcinoma (HT-29). For comparison purposes, the cy-
totoxicity of 5-fluorouracile (5-FU) was evaluated under the
same experimental conditions, using the sulforhodamine B
(SRB) assay [27]. 5e cytotoxicity of the compounds was
calculated from their IC50 values (the micromolar concen-
tration of compound that inhibits 50% cell growth).
5e antiproliferative activity of the thiosemicarbazones
derivatives and 5-fluorouracile is shown in Table 3. 5e
obtained results indicate that 1 was more cytotoxic
(IC50 = 3.36–21.35 μM) than the other tested thio-
semicarbazones (IC50 = 40.0–>582.26 μM) against all the
tested cell lines. 5ese results allow to confirm that the
cytotoxic activity is enhanced when the OCH2CF3 substit-
uent group is bound in the C-6 position of the pyridine ring
[44]. As compared to the 5-fluorouracile (5-FU) anticancer
agent (IC50 = 7.51 μM), 1 exhibited a higher cytotoxic effect
at low micromolar concentration (IC50 = 3.6 μM) against the
amelanotic melanoma cell line (M-14). In addition, 1
showed to be more innocuous (IC50 = 6.12 μM) than 5-FU
(IC50 =< 0.47 μM) against the BALB/3T3 mouse embryo
normal cells.
On the other hand, 5 (X� 3, 4-dimethoxyphenyl)
showed a more acceptable cytotoxicity
(IC50 � 40.34–43.04 μM) than 8 (X� 3, 5-dichorophenyl),
with IC50 values of >384.36 μM against the HuTu80 and
DU145 cell lines. 5ese results indicate that the presence of
the methoxy substituent groups in the C-3 and C-4 positions
of the benzene ring enhance the antitumor activity against
these specific cell lines.
Compound 1 tested in vitro against the amelanotic
melanoma cell line (M-14) (IC50 = 3.36 μM) showed to be
more cytotoxic as compared to pyridine-2-carbaldehyde
thiosemicarbazone (IC50 => 100 μM) assayed in vitro
against the mouse metastatic skin melanoma (B16F10)
cell line [44]. Nevertheless, 1 (IC50 = 11.25 μM) tested in
vitro against the colon adenocarcinoma (HT-29) was
slightly less active than pyridine-2-carbaldehyde thio-
semicarbazone (IC50 = 8.6 μM) and 2-acetylpyridine-
N(4)-orthochlorophenyl thiosemicarbazone
(IC50 = 6.96 μM) assayed in vitro against the colon cancer
(CT26.WT) and HT-29 cell lines, respectively [44, 45].
On the other hand, 3-aminepyridinecarbaldehyde thio-
semicarbazone and 3-phenyl-1-pyridin-2-ylprop-2-en-1-
one thiosemicarbazone tested in vitro against the large
cell lung cancer (NCI-H460) [46] and the human breast
carcinoma (MDA-MB 231) cell line [10], respectively,
were found to be about two times more cytotoxic than 1
tested in vitro against the H460 and MCF-7 cell lines with
IC50 values of 10.9 and 6.27 μM, respectively. However, 1
(IC50 = 6.27 μM) was more active than 4-phenyl-1-
(quinoline-2-carbaldehyde) thiosemicarbazone
(IC50 => μM) [47] and diacetylpyridine bis(4N-tolylth-
iosemicarbazone) (IC50 => 100 μM) assayed on the MCF-
7 cell line [41]. In addition, 1 (IC50 = 10.90 μM) tested on
the H460 cell line showed higher cytotoxicity than 2-
acetyl-pyridine thiosemicarbazone (IC50 = 14.34 and
15.68 μM) and 4-methyl-1-(2-acetyl-pyridine) thio-
semicarbazone (IC50 = 11.10 and 15.53 μM) assayed
against the NCI-H460 and MSTO-211H lung carcinoma
cell lines, respectively [48].
5e selectivity indexes which represent the ratio of the
IC50 values of the compounds on non-tumor cell line to
those in the tumor cell line were calculated in order to
determine if the pyridine-3-carbaldehyde thio-
semicarbazone derivatives (1–8) were more cytotoxic on
tumor cell lines compared with the 3T3 non-tumor cell
line, and the results have been summarized in Table 4.
Considering the low IC50 values obtained for the tested
compounds against the tumor and non-tumor cell lines, 1
displayed the highest selectivity index (SI = 1.82) against
M-14 cell line as compared to those indexes observed for
the other tested thiosemicarbazones and the 5-fluorouracile
chemotherapeutic agent. 5is value means that compound
1 is 1.82 times more cytotoxic to the tumor cell line as
compared to the 3T3 non-tumor cell line. 5is value can be
considered as an acceptable selectivity index with respect to
the highest selectivity index (2.81) found for the essential
oil from T. erecta leaves against HT-29 tumor cell line and
Table 3: IC50 (μM) valuesa of the pyridine-3-carbaldehyde thiosemicarbazone derivatives (1–8) against the 3T3 non-tumor cells and the
different human tumor cell lines.
Comp.
Non-tumor cells Tumor cells
3T3b H460 HuTu80 DU145 MCF-7 M-14 HT-29
5-FU c <0.47 3.65± 0.81 3.68± 0.65 7.51± 0.98 2.45± 0.28 7.51± 0.73 4.54± 0.86
1 6.12± 0.33 10.90± 0.42 7.17± 0.35 21.35± 0.78 6.27± 0.24 3.36± 0.10 11.25± 0.41
2 >455.67 >455.67 >455.67 >455.67 >455.67 >455.67 >455.67
3 >582.26 >582.26 389.22 + 10.42 582.26± 13.74 >582.26 >582.26 >582.26
4 60.49± 5.90 98.15± 4.12 40.00± 3.93 66.53± 2.46 73.17± 4.38 140.07± 1.90 232.35± 24.35
5 24.69± 2.45 52.95± 4.29 40.34± 3.56 43.04± 2.24 78.24± 4.92 >395.09 98.77± 6.73
6 537.24± 44.83 >537.24 215.47± 12.83 537.24± 14.04 348.36± 9.53 >537.24 537.24± 15.68
7 168.34± 6.36 254.79± 10.21 126.23± 9.74 183.09± 22.54 151.95± 9.12 102.08± 16.74 134.64± 10.51
8 >384.36 >384.36 >384.36 >384.36 >384.36 >384.36 >384.36
aIC50 corresponds to the concentration required to inhibit a 50% of the cell growth when the cells are exposed to the respective compound during 48 h. 5e
values are mean± standard deviation of two independent experiments. bMouse embryonic fibroblast cells. c5-fluorouracile.
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VT79 normal hamster lung fibroblast cells [49]. On the
other hand, 6 displayed the highest selectivity indexes of
2.49 and 1.54 against HuTu80 and MCF-7 cell lines, re-
spectively, with respect to the other tested thio-
semicarbazone derivatives. However, the IC50 values were
very high (>200 μM) for both tumor cell lines.
5us, it becomes evident that the studied thio-
semicarbazones have a different activity depending on the
substituents present in the respective structures. However, 2,
3, and 6, even though the most innocuous compounds
against the 3T3 normal cells do not present antitumor ac-
tivity against the studied cell lines.
4. Conclusions
In this study, eight new pyridine-3-carbaldehyde thio-
semicarbazone derivatives with different substituents
were synthesized, characterized, and investigated for
their antitumor activities. Only 7 gave good quality
crystals for single crystal X-ray diffraction studies. 5e
crystal structure of 7 exhibits an E conformation about
the N2-N3 bond. 5is conformation was also assessed
from solution 1H NMR studies. 5e results of the cyto-
toxic assays and the selectivity indexes calculated dem-
onstrated that compound 1 with IC50 value of 3.36 μM
and selectivity index of 1.82 has significant bioactivity
towards amelanotic melanoma (M14) human tumor cell
line. 5erefore, 1 is a promising candidate as a phar-
macological agent, since it presents significant activity
and is more innocuous than the 5-fluorouracile anti-
cancer drug against 3T3 mouse embryo fibroblast normal
cells. Further studies are required to evaluate the
mechanism of action for the anticancer activity of 1.
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H460 HuTu80 DU145 MCF-7 M-14 HT-29
5-FU b <0.13 <0.13 <0.06 <0.19 <0.06 <0.10
1 0.56 0.85 0.29 0.98 1.82 0.54
2 NC NC NC NC NC NC
3 NC >1.50 1.00 NC NC NC
4 0.62 1.51 0.91 0.83 0.43 0.26
5 0.47 0.61 0.57 0.32 <0.06 0.25
6 <1.00 2.49 1.00 1.54 <1.00 1.00
7 0.66 1.33 0.92 1.11 1.65 1.25
8 NC NC NC NC NC NC
a5e selectivity index is the ratio of the IC50 values of the compounds on 3T3 cells to those in the tumor cell lines. NC� unable to calculate. b5-Fluorouracile.
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